Ching Tai Technology reaches over $400 million in AI drug discovery collaboration with international pharmaceutical companies.

On June 10th, Jingtai Technology announced that it has reached a strategic cooperation with an internationally renowned biopharmaceutical company with a rich pipeline and multiple commercial products, totaling over 400 million US dollars in AI drug discovery. The two parties will jointly develop an innovative oral small molecule drug with "best-in-class" potential targeting a GPCR target.